RT30

$450.00

RT30 mg (LY-3437943) – High-Purity Research Peptide

Retatrutide is an advanced lyophilized peptide, offered in a 30mg vial, designed exclusively for scientific research and laboratory study. Developed by Eli Lilly & Co., this triple agonist targets three key receptors:

  • GLP-1R (glucagon-like peptide-1 receptor)

  • GIPR (glucose-dependent insulinotropic polypeptide receptor)

  • GCGR (glucagon receptor)

With high potency and >99% HPLC-verified purity, Retatrutide is a cutting-edge tool in the study of obesity, metabolic syndrome, insulin sensitivity, and lipid metabolism.

Key Features

  • Purity: >99% (HPLC verified)

  • Form: Lyophilized powder (requires reconstitution)

  • Molecular Formula: C₂₁₅H₃₄₁N₆₃O₆₄

  • Molecular Weight: 4899.84 g/mol

  • CAS Number: 2381089-83-2

  • Quantity: 30mg per vial

Research Application

Retatrutide demonstrates high-affinity receptor agonism in human assays:

  • GCGR: EC₅₀ = 5.79 nM

  • GIPR: EC₅₀ = 0.0643 nM

  • GLP-1R: EC₅₀ = 0.775 nM

These interactions offer valuable insights into

  • Appetite regulation

  • Energy homeostasis

  • Glucose and lipid metabolism

  • Weight management mechanisms

  • Cardiometabolic research

Its multi-receptor synergy offers a unique opportunity to explore the future of combination therapies in metabolic health.

Storage & Handling

  • Store at –20°C to –80°C (stable for up to 2 years at –80°C)

  • Protect from light and moisture

  • Reconstitute with sterile water or a suitable solvent (e.g., DMSO, freshly sourced if hygroscopic)

Important Notices

  • For Research Use Only
    Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease.

  • Regulatory Compliance
    Buyers are solely responsible for all applicable laws and regulations in their jurisdiction.

  • Laboratory Handling Only
    Use only by qualified professionals in controlled lab settings.

Why Choose Retatrutide 30mg. With its potent triple-agonist profile and unmatched receptor activity, Retatrutide offers researchers a powerful platform for exploring advanced metabolic pathways and experimental obesity therapies. Trusted for its purity, reliability, and performance, it is an essential component for laboratories investigating the future of metabolic disease research.

Disclaimer: This product is sold strictly for research purposes only. By purchasing, you affirm that you are a qualified professional and agree to use it in accordance with all local regulations.

RT30 mg (LY-3437943) – High-Purity Research Peptide

Retatrutide is an advanced lyophilized peptide, offered in a 30mg vial, designed exclusively for scientific research and laboratory study. Developed by Eli Lilly & Co., this triple agonist targets three key receptors:

  • GLP-1R (glucagon-like peptide-1 receptor)

  • GIPR (glucose-dependent insulinotropic polypeptide receptor)

  • GCGR (glucagon receptor)

With high potency and >99% HPLC-verified purity, Retatrutide is a cutting-edge tool in the study of obesity, metabolic syndrome, insulin sensitivity, and lipid metabolism.

Key Features

  • Purity: >99% (HPLC verified)

  • Form: Lyophilized powder (requires reconstitution)

  • Molecular Formula: C₂₁₅H₃₄₁N₆₃O₆₄

  • Molecular Weight: 4899.84 g/mol

  • CAS Number: 2381089-83-2

  • Quantity: 30mg per vial

Research Application

Retatrutide demonstrates high-affinity receptor agonism in human assays:

  • GCGR: EC₅₀ = 5.79 nM

  • GIPR: EC₅₀ = 0.0643 nM

  • GLP-1R: EC₅₀ = 0.775 nM

These interactions offer valuable insights into

  • Appetite regulation

  • Energy homeostasis

  • Glucose and lipid metabolism

  • Weight management mechanisms

  • Cardiometabolic research

Its multi-receptor synergy offers a unique opportunity to explore the future of combination therapies in metabolic health.

Storage & Handling

  • Store at –20°C to –80°C (stable for up to 2 years at –80°C)

  • Protect from light and moisture

  • Reconstitute with sterile water or a suitable solvent (e.g., DMSO, freshly sourced if hygroscopic)

Important Notices

  • For Research Use Only
    Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease.

  • Regulatory Compliance
    Buyers are solely responsible for all applicable laws and regulations in their jurisdiction.

  • Laboratory Handling Only
    Use only by qualified professionals in controlled lab settings.

Why Choose Retatrutide 30mg. With its potent triple-agonist profile and unmatched receptor activity, Retatrutide offers researchers a powerful platform for exploring advanced metabolic pathways and experimental obesity therapies. Trusted for its purity, reliability, and performance, it is an essential component for laboratories investigating the future of metabolic disease research.

Disclaimer: This product is sold strictly for research purposes only. By purchasing, you affirm that you are a qualified professional and agree to use it in accordance with all local regulations.